Literature DB >> 2135633

HIV seroprevalence among male IVDUs in Houston, Texas.

M L Williams.   

Abstract

HIV seroprevalence was 8.4 percent in a sample of 921 heterosexual male intravenous drug users in Houston, Texas who were not in drug treatment at the time of the study. Males who were Black, injected drugs daily, or had a history of syphilis had greater odds of being HIV positive than participants without those characteristics.

Entities:  

Mesh：

Year:  1990        PMID： 2135633      PMCID： PMC1405124          DOI： 10.2105/ajph.80.12.1507

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  12 in total

1.  Sampling rare and elusive populations.

Authors:  S Sudman; M G Sirken; C D Cowan
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

2.  Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. First Drug User Multicenter Study Group.

Authors:  H Sasse; S Salmaso; S Conti
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

3.  Birthplace and the risk of AIDS among Hispanics in the United States.

Authors:  R M Selik; K G Castro; M Pappaioanou; J W Buehler
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

4.  Preventing AIDS contagion among intravenous drug users.

Authors:  J A Newmeyer; H W Feldman; P Biernacki; J K Watters
Journal:  Med Anthropol       Date:  1989-03

5.  AIDS and the new drug injector.

Authors:  S R Friedman; D C Des Jarlais; A Neaigus; A Abdul-Quader; J L Sotheran; M Sufian; S Tross; D Goldsmith
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

6.  Racial/ethnic differences in the risk of AIDS in the United States.

Authors:  R M Selik; K G Castro; M Pappaioanou
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

7.  Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City.

Authors:  D C Des Jarlais; E Wish; S R Friedman; R Stoneburner; S R Yancovitz; D Mildvan; W el-Sadr; E Brady; M Cuadrado
Journal:  N Y State J Med       Date:  1987-05

8.  Epidemiology of HIV infection and AIDS in the United States.

Authors:  J W Curran; H W Jaffe; A M Hardy; W M Morgan; R M Selik; T J Dondero
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

9.  HIV infection among persons who inject illicit drugs: problems and prospects.

Authors:  D C Des Jarlais; S R Friedman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

Review 10.  Prevalence of HIV infection among intravenous drug users in the United States.

Authors:  R A Hahn; I M Onorato; T S Jones; J Dougherty
Journal:  JAMA       Date:  1989-05-12       Impact factor: 56.272
View more
  6 in total

1.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

2.  History, biography, and HIV infection.

Authors:  S R Friedman; P H Kleinman; D C Des Jarlais
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

3.  Seroprevalence of HIV-1 and hepatitis B and C in prostitutes in Albuquerque, New Mexico.

Authors:  S R Tabet; D L Palmer; W H Wiese; R E Voorhees; D R Pathak
Journal:  Am J Public Health       Date:  1992-08       Impact factor: 9.308

4.  The consistency of self-reported HIV risk behavior among injection drug users.

Authors:  K McElrath; D D Chitwood; D K Griffin; M Comerford
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

5.  Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Holly Hagan; Courtney McKnight; David C Perlman; Samuel R Friedman
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

6.  HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.

Authors:  H A Siegal; R G Carlson; R Falck; L Li; M A Forney; R C Rapp; K Baumgartner; W Myers; M Nelson
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.